Rui Ping Dong
Chief Executive Officer at Shanghai Haihe Biopharma Co., Ltd.
Rui Ping Dong active positions
Companies | Position | Start | End |
---|---|---|---|
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Director/Board Member | 2018-05-29 | - |
Chief Executive Officer | 2018-10-29 | - | |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | Director/Board Member | 2020-06-30 | - |
Jiangsu Synecoun Medical Technology Co. Ltd.
Jiangsu Synecoun Medical Technology Co. Ltd. Medical SpecialtiesHealth Technology Jiangsu Synecoun Medical Technology Co. Ltd. is a company that manufactures medical devices. The company is based in Jiangsu, China. | Director/Board Member | - | - |
Career history of Rui Ping Dong
Former positions of Rui Ping Dong
Companies | Position | Start | End |
---|---|---|---|
Merck & Co. | Chief Tech/Sci/R&D Officer | 2009-12-31 | 2012-12-31 |
Training of Rui Ping Dong
Kyushu University | Doctorate Degree |
Jiangxi Medical College | Graduate Degree |
Statistics
International
China | 4 |
United States | 3 |
Japan | 2 |
Operational
Director/Board Member | 3 |
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 4 |
---|---|
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Commercial Services |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | Health Technology |
Jiangsu Synecoun Medical Technology Co. Ltd.
Jiangsu Synecoun Medical Technology Co. Ltd. Medical SpecialtiesHealth Technology Jiangsu Synecoun Medical Technology Co. Ltd. is a company that manufactures medical devices. The company is based in Jiangsu, China. | Health Technology |
Merck & Co. | Finance |
- Stock Market
- Insiders
- Rui Ping Dong
- Experience